Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
NCT01448720
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Paliperidone palmitate
Sponsor
Janssen-Cilag Farmaceutica Ltda.